جست‌وجوی استاد و پژوهشگر

• Molecular Biology
• Cancer Biology
• Bioinformatics
• +۶ مورد دیگر

Gabriele Bucci is a researcher affiliated with the Italian Institute of Technology (IIT) and has conducted significant research at the European Institute of Oncology (IEO), Milan. His work integrates molecular biology and bioinformatics to study cancer mechanisms, particularly focusing on gene regulation and tumor development. His research interests lie at the intersection of molecular oncology and computational genomics. He investigates long non-coding RNAs (such as lncRNA EPR), their role in gene regulation, and their impact on diseases like intestinal inflammation, ovarian cancer, and leukemia. His work often involves multi-omics approaches, combining genomics, transcriptomics, and epigenetics to uncover regulatory networks in cancer. The recent publication trends show a strong emphasis on lncRNA biology, tumor microenvironment, immune responses in cancer, and clinical genomics applications in lung and esophageal cancers. His contributions span both basic molecular mechanisms and translational applications in precision oncology. Associate Editor, Computational Genomics, Frontiers in Genetics He has contributed to editorial work in computational genomics but no formal grants or advising roles are documented. His collaborative network includes leading researchers in oncology and genomics across Italian institutions. He is actively engaged in advancing genomic medicine through large-scale sequencing and functional genomics studies.

Iris E.C. Sommerمشاهده پروفایل

استاد

• Psychiatry
• Neuroscience
• Schizophrenia Research
• +۵ مورد دیگر

Professor Iris E.C. Sommer is a distinguished psychiatrist and neuroscientist at the University of Groningen's Faculty of Medical Sciences, where she leads research in the Clinical Cognitive Neuropsychiatry Research Program (CCNP) and the Biology-Related, Artificial, and Interventional Neuroscience (BRAIN) group. With over 444 research outputs and significant contributions to psychiatric science, she holds editorial positions at major journals including Schizophrenia Bulletin, Psychological Medicine, and Lancet Psychiatry. Dr. Sommer's research primarily focuses on schizophrenia and psychosis spectrum disorders, with particular expertise in hallucinations, semantic processing abnormalities, and the gut-brain axis. Her work integrates neuroimaging, computational linguistics, and clinical psychiatry to develop novel biomarkers and treatment approaches. She has pioneered research on sex differences in brain structure and mental health, as well as the role of intestinal permeability in psychiatric disorders. Her recent publications demonstrate a strong emphasis on longitudinal studies of psychosis, international collaborative research on mental health during the pandemic (COH-FIT study), pharmacogenetics of schizophrenia treatment, and algorithmic approaches to treatment guidelines. These works span multiple disciplines including neuroscience, psychiatry, linguistics, and gastroenterology, reflecting her interdisciplinary approach to mental health research. Professor Sommer has received notable recognition including the NWO Science Communication Initiative Award 2024, Distinguished Lorentz Fellowship 2022/23, and Huibregtsenprijs 2022. She was also nominated for the Woman in the Media Award in 2024 for her public engagement efforts. As an active supervisor and science communicator, she has examined PhD students and leads initiatives like Marvelous Mind to make neuroscience accessible to the public. She frequently presents at professional conferences and gives public talks on topics ranging from the gut-brain connection to women's mental health. Her laboratory work centers around the Clinical Cognitive Neuropsychiatry Research Program, where her team investigates the neural mechanisms underlying psychotic symptoms using multimodal approaches including neuroimaging, linguistic analysis, and clinical assessments. She also collaborates extensively with international researchers through projects like the COH-FIT consortium.

Zhiheng Peiمشاهده پروفایل

دانشیار مدعو

• Microbiome in Chronic Diseases
• Human Microbiome Research
• Gastrointestinal Microbiome
• +۷ مورد دیگر

Zhiheng Pei is an Adjunct Associate Professor in the Department of Pathology at Vanderbilt University School of Medicine. Education: PhD from Vanderbilt University, MD from Jiamusi University School of Medicine His research focuses on microbiome-related etiology of chronic diseases, particularly gastrointestinal and oral microbiome dynamics in cancer development. Key projects include defining microbiome associations with esophageal adenocarcinoma, gastric cancer risk, and chronic tonsillar hypertrophy pathogenesis. Recent publications highlight interdisciplinary collaborations using metagenomic shotgun sequencing, molecular pathology techniques, and gut microbiome analysis across diverse populations. While no formal students are listed, his work involves mentoring residents and fellows in clinical microbiome applications.

• Allergy
• Immunology
• Toxicology
• +۶ مورد دیگر

Carine Delayre-Orthez is a French Lecturer-researcher and Associate Professor currently serving as Head of the College of Health Sciences at UniLaSalle . With a doctorate in pharmacology and toxicology from University of Strasbourg , she has led research at the intersection of immunology, toxicology, and nutrition since 2004. Education: Doctorate in pharmacology and toxicology (University of Strasbourg) Current Roles: Head of College of Health Sciences, Associate Professor Prior Affiliation: Assistant Professor at University of Strasbourg (2004-2005) Her research focuses on allergen-induced inflammation , advanced glycation end-products (AGEs) , and nutritional programming of immune responses . She investigates how dietary compounds like polyphenols and iron modify gut microbiota and chronic low-grade inflammation (CLGI). Key publication trends include: Dose-response studies of AGEs and contaminants Therapeutic potential of synbiotics in gluten sensitivity Epigenetic impacts of early-life nutritional interventions PPARα receptor modulation of airway inflammation Development of in vitro intestinal barrier models Translational studies on food allergy treatments Professional networks include academic collaborations with UPJV (Peritox Unit) and INRA (BIA-ALL Unit), plus industrial partnerships with DBV Technologies , Biomerieux , and ABCD Nutrition .

Andrew Gewirtzمشاهده پروفایل

استاد

• Innate Immunity
• Microbiome
• Intestinal Inflammation
• +۲ مورد دیگر

Andrew Gewirtz is a Regents’ Professor and Distinguished University Professor at Georgia State University's Institute for Biomedical Sciences, where he conducts pioneering research on innate immunity, the gut microbiome, intestinal inflammation, and metabolic disorders including obesity and diabetes. His work centers on understanding how pro-inflammatory pathways protect against microbes and become dysregulated in disease states, with primary focus on the intestinal epithelium as a critical host-microbe interface. Education: Ph.D. in Biochemistry, Boston University School of Medicine, 1996 Dr. Gewirtz's research investigates how the intestinal epithelium maintains homeostasis through antimicrobial production and immune cell recruitment, and how disruptions lead to chronic inflammation. His laboratory has established fundamental connections between Toll-like receptor signaling (particularly TLR5), gut microbiome composition, and metabolic syndrome. Key discoveries include demonstrating that TLR5 deficiency causes dysbiosis leading to obesity and colitis, and identifying flagellin as a critical microbial factor driving inflammatory responses. His publication record (2005-2012) reveals consistent focus on host-microbe interactions, with dominant themes in TLR5 signaling, Proteobacteria-driven inflammation, and the microbiome's role in metabolic disease. The work predominantly employs mouse models to dissect molecular mechanisms linking innate immunity to gut barrier function and systemic inflammation. Scientific Awards: Regents’ Professor Distinguished University Professor Dr. Gewirtz maintains an active research program with extensive collaborations across immunology and microbiome research. His laboratory at Georgia State's Petit Science Center generates foundational insights into inflammatory pathways, with implications for treating inflammatory bowel disease, obesity, and diabetes. While specific grant details aren't provided, his high-impact publications indicate substantial research support. His laboratory focuses on experimental models of gut inflammation, microbial community analysis, and molecular dissection of epithelial-immune interactions, directly contributing to translational applications in inflammatory and metabolic disorders.

Amy O'Connellمشاهده پروفایل

استادیار

• Developmental Biology
• Neonatal Immunity
• Intestinal Stem Cell Biology
• +۹ مورد دیگر

Amy O'Connell is a physician scientist at Boston Children's Hospital and an Assistant Professor of Pediatrics at Harvard Medical School. She specializes in neonatal immunity, intestinal development, and genetic orphan diseases. Her clinical roles include Director of Infection Control in the Neonatal ICU and Faculty in the Neonatal Genomics Program. MD/PhD : Jefferson Medical College (2009), Merrimack College (2002) Training : University of Vermont (Pediatrics Residency), Boston Children's Hospital (Allergy/Immunology Fellowship), Harvard (Neonatal-Perinatal Fellowship) Her research focuses on developmental biology and neonatal immunity, particularly intestinal stem cell transitions, immune maturation in preterm infants, and the role of WNT2B in intestinal and adrenal disorders. The O'Connell Lab (Neonatal Intestinal and Immune Center for Exploration) investigates necrotizing enterocolitis (NEC), Prematurity Related Immune Dysfunction (PRID), and orphan disease characterization. Recent publications highlight her work on Wnt signaling, microbiome-immunity interactions, and clinical tools for NICU sepsis management. She is certified in Pediatrics, Allergy & Immunology, and Neonatal-Perinatal Medicine by the American Board of Pediatrics. Dr. O'Connell's lab emphasizes diversity, equity, and translational approaches to neonatal care, including regenerative strategies for intestinal disorders and neonatal gene therapies. She has contributed to understanding immune dysfunction in preterm infants and inflammatory cytokine dynamics in colitis models.

Eduardo Mascarenoمشاهده پروفایل

استادیار

• Molecular Cardiology
• Jak/Stat Signaling Pathways
• Renin-Angiotensin System
• +۲ مورد دیگر

Eduardo Mascareno is an Assistant Professor in the Department of Cell Biology at SUNY Downstate Health Sciences University, specializing in molecular mechanisms linking obesity, cardiovascular disease, and cellular signaling pathways. His research focuses on leptin's role in cardiovascular regulation, Jak/Stat signaling, and the local tissue renin-angiotensin system (RAS) during cardiac hypertrophy. Institution: SUNY Downstate Health Sciences University Department: Cell Biology Academic Rank: Assistant Professor Email: emascareno@downstate.edu Key research themes include: Leptin receptor signaling in cardiovascular tissues Jak/Stat pathway activation in cardiac RAS regulation Hexim1's role in obesity-glucose metabolism links Myeloid inflammation states in renal cancer recurrence Transcriptional regulation during heart development Recent publications examine: 2022: Myeloid inflammatory states in renal cancer recurrence 2021: Mental health impacts of pandemic on respiratory patients 2020: Leptin's differential regulation of lipid metabolism 2017: Hexim1's protective roles in infectious and metabolic diseases 2012: Cross-regulation of cancer signaling networks 2009: Cardiac gene expression during hypertrophy

Dakshina (Moody) Jandhyalaمشاهده پروفایل

استادیار

• Bacterial Pathogenesis
• Toxin-Mediated Diseases
• Cell Death Signaling
• +۴ مورد دیگر

Dakshina Jandhyala is a Research Assistant Professor at the University of Houston College of Pharmacy's Department of Pharmacological and Pharmaceutical Sciences. She directs the Core Research Laboratories & Facilities, focusing on bacterial toxin mechanisms and inflammatory signaling. Ph.D., Molecular Biology, University of Houston B.S., Biology, University of Texas Her research investigates how bacterial and plant toxins damage ribosomes to trigger cell death and inflammation, while exploring gut microbiota interactions and probiotic modulation of intestinal immunity. Recent publications analyze ZAK kinase's role in toxin signaling, 3D renal models for Stx2 toxicity, and ER stress responses to Subtilase toxin. 2013 Tufts Collaborates! Grant 2012 Charlton Research Grant 2011 NIH/Tufts CTSI Grant As a journal reviewer for 8+ publications, she contributes to peer review in microbiology and pharmacology fields.

Jun Seok Sonمشاهده پروفایل

استادیار

• Exercise Physiology
• Obesity
• Epigenetics
• +۴ مورد دیگر

Dr. Jun Seok Son is an Assistant Professor at the University of Maryland School of Medicine, with a primary appointment in the Department of Obstetrics, Gynecology and Reproductive Sciences and a secondary appointment in the Department of Physiology. His research focuses on the molecular and epigenetic mechanisms linking maternal exercise to fetal development and offspring metabolic health. 2012 BS in Kinesiology, Korea National Sport University 2016 MS in Exercise Physiology, Seoul National University 2020 PhD in Nutrigenomics and Growth Biology, Washington State University 2021 Postdoc in Bioinformatics & Molecular Biosciences, Washington State University Dr. Son’s work explores how maternal exercise modifies placental vascularization and stem cell differentiation via exerkines like apelin, mitigating obesity-induced metabolic dysfunction in offspring. His studies emphasize epigenetic regulation of myogenesis, adipogenesis, and organ development through pathways such as AMPK and mitochondrial biogenesis. His recent publications highlight maternal exercise’s protective effects against sarcopenic obesity, NAFLD, and placental dysfunction in offspring. Themes include apelin signaling, muscle-bone crosstalk, and intestinal/endothelial homeostasis. Dr. Son leads the Nutrigenomics & Perinatal Exercise Biology Laboratory, mentoring PhD and postdoc candidates. His work has been featured by the NIH and widely covered in media outlets such as BBC Science Focus Magazine.

• Gut-Brain Axis
• Microbiome Research
• Neuroinflammation
• +۳ مورد دیگر

Stephen Michael Collins is a distinguished Professor in the Department of Medicine at McMaster University , where he has been a faculty member since 1981. He has held leadership roles including Director of the Intestinal Diseases Research Unit (1983-2017), Chief of Gastroenterology (1993-2006), and Associate Dean for Research (2006-2017). He currently serves as Director of the Farncombe Family Digestive Health Research Institute , which he founded. Medical training: University College & Westminster Hospital, London Specialization: Gastroenterology, Neurogastroenterology His research focuses on the gut-brain axis , particularly how intestinal microbiota modulates neuroinflammation and behavior in health and disease. His work bridges gastroenterology , immunology , and neuroscience , with over 300 publications. Recent studies investigate microbial phospholipids in visceral hypersensitivity, dietary interventions for IBS, and stress-microbiota interactions. Scientific honors include: Fellow of the Royal Society of Canada President of the Canadian Association of Gastroenterology His 15 most recent articles (2014-2025) reveal trends in microbiota-gut-brain axis research, with specific emphasis on lysophospholipid signaling , histamine metabolism , visceral pain mechanisms , and stress-induced microbial translocation . Collaborative work with Canadian Institutes of Health Research and Crohn's Colitis Canada highlights clinical translation.

Nikhil Joshiمشاهده پروفایل

دانشیار

• Tumor Immunology
• T Cell Differentiation
• Cancer Immunotherapy
• +۵ مورد دیگر

Nikhil Joshi is an Associate Professor in the Department of Immunobiology at Yale University, with affiliations to the Yale Cancer Center and Yale Center for Immuno-Oncology. His research focuses on T cell immunology in cancer and infection contexts. Yale Cancer Center Yale Center for Immuno-Oncology Human and Translational Immunology Program Research Interests: The Joshi laboratory investigates immune cell interactions with developing tumors using complex mouse models. They study T cell differentiation in cancer and infection, focusing on peripheral tolerance mechanisms, tumor microenvironment dynamics, and therapeutic modulation of immune responses. Publication Trends: Recent work spans cancer immunotherapy models (2025), KLF2 regulation in T cell exhaustion (2025), single-cell gene mapping (2024), tertiary lymphoid structures (2024), and immunometabolism (2024). Earlier publications established neoantigen systems (2020) and tissue-specific tolerance models (2018). Scientific Awards: Class of 1961 Cancer Research Award Basic Science Research Prize Pershing Square Sohn Prize Emerging Leader Award James B. Dougherty MD Award Lab & Collaborations: The Joshi Lab at Yale's Anlyan Center develops advanced tumor models. They collaborate with computational biologists, clinical teams, and immunology researchers to bridge fundamental discoveries with translational applications.

• Dietary modulation of intestinal health and chronic disease
• Diet-microbiome and host intestinal epithelium interaction
• Dietary modulation of intestinal barrier integrity and function
• +۳ مورد دیگر

Dr. Krista Anne Power is an Associate Professor at the School of Nutrition Sciences , University of Ottawa, with Adjunct Professor roles at the University of Guelph and University of Toronto. Her research focuses on dietary modulation of intestinal health and chronic disease prevention , particularly in inflammatory bowel disease (IBD) , obesity , and systemic inflammation . BSc in Nutrition/Biochemistry, Memorial University of Newfoundland MSc and PhD in Nutritional Science, University of Toronto Post-doctoral fellowships at University of Turku (EU CASCADE) and Karolinska Institute Her work investigates how bioactive food components like flaxseed, common beans, and apples alter gut microbiota , mucosal barrier integrity , and immune responses using in vivo , ex vivo , and in vitro models. Current projects funded by NSERC , Ontario Research Fund , and OMFRA explore flaxseed ideotypes, bean genomic breeding, and apple consumption in gut health and metabolic dysfunction mitigation. Recent publications (2018–2015) emphasize diet-microbiome interactions , anti-inflammatory diets , and phytochemical impacts on colonic barrier function and obesity-related inflammation . She actively recruits trainees and leads collaborative projects with institutions like the University of Guelph.

David Hoytema van Konijnenburgمشاهده پروفایل

مدرس

• Immunology
• Pediatrics
• Inflammatory Bowel Disease
• +۶ مورد دیگر

David Hoytema van Konijnenburg is an attending physician in the Division of Immunology at Boston Children's Hospital and an instructor at Harvard Medical School. His clinical and research focus centers on tissue-resident immune cells in the lung, skin, and tumors, with a specialization in immune dysregulation syndromes, immunodeficiency, and immunogenetics for rare immune disorders. Education: MD and PhD from Utrecht University (2014 and 2018), residency at Boston Combined Residency Program (2021), fellowship in Allergy/Immunology at Boston Children's Hospital (2024). His research explores mechanisms of intestinal immunity, respiratory immunology, and genetic defects in immune homeostasis. Key publications span topics including T cell compartmentalization in inflammation , immunometabolic adaptations , viral infection complications in immunodeficiency , and genetic penetrance in rare immune disorders . Articles consistently emphasize tissue-specific immune responses across mucosal and respiratory systems. Dr. Hoytema van Konijnenburg's clinical work integrates scientific approaches to diagnosis and treatment of rare immune conditions. He is board-certified in Pediatrics and Allergy/Immunology, and actively participates in programs like MIDAS, Immunogenetics, and Interstitial Lung Disease initiatives.

Douglas D. Demingمشاهده پروفایل

استاد

• Neonatology
• Preterm Infant Care
• Bronchopulmonary Dysplasia (BPD)
• +۵ مورد دیگر

Douglas D. Deming, MD is a Professor at Loma Linda University School of Medicine in the Neonatology Division of the Department of Pediatrics . He holds an MD from Loma Linda University (1975) and a BA from Walla Walla University (1972). His career spans clinical research, grants, and leadership in neonatal care. Education : MD (1975), BA (1972) Key Appointments : Professor in Pediatrics, Principal Investigator for multiple NIH and LLU grants Research Interests focus on preterm infant care, including: Patent Ductus Arteriosus (PDA) management Procedural pain and oxidative stress Respiratory distress and hypoxia Neurological outcomes in neonatal conditions Publication Trends (2025–2020) highlight work on: Glucocorticoid sensitivity in preterm newborns Impact of PDA treatments on necrotizing enterocolitis and intraventricular hemorrhage Non-pharmacological pain interventions Neurological and metabolic biomarkers Grants include NIH-funded studies on pain/hypoxia in preterm neonates and LLU internal projects on oxidative stress, gene expression, and neonatal monitoring. Service roles encompass chairing the Children's Hospital Patient Care Committee and international teaching missions in China.

Justin L. Sonnenburgمشاهده پروفایل

استاد

• Gut Microbiota
• Host-Microbe Interactions
• Diet and Microbiome
• +۱۱ مورد دیگر

Justin L. Sonnenburg is the Alex and Susie Algard Endowed Professor in the Department of Microbiology and Immunology at Stanford University School of Medicine . He holds additional appointments as a member of Bio-X, Wu Tsai Human Performance Alliance, Maternal & Child Health Research Institute (MCHRI), and Stanford Medicine Children’s Health Center for IBD and Celiac Disease. B.S. , Biochemistry, UC Davis (1996) Ph.D. , Biomedical Sciences, UC San Diego (2003) His research focuses on gut microbiota dynamics , host-microbe interactions , and microbiome-based therapies . Key areas include dietary impacts on microbiomes, synthetic biology tools for microbial engineering, and ecological consequences of industrialization on microbial communities. His lab employs gnotobiotic mice , metabolomics pipelines , and metagenomic sequencing to explore these themes. Recent publications highlight engineered prebiotic niches (2025), IgA-microbiota interactions (2025), Hadza microbiome conservation (2023), and multi-omics dietary interventions (2021-2022). His 2021-2025 work bridges microbial strain analysis , immune profiling , and population-scale microbiome comparisons . NIH Director's New Innovator Award (2009) Burroughs Wellcome Fund Investigator (2011) NIH Director's Pioneer Award (2017) AGA Research Mentor Award (2023) He teaches Frontiers in Microbiology and Immunology and mentors 12 doctoral/postdoctoral researchers. His clinical trials examine keto vs mediterranean diets and vegan vs omnivore microbiomes . Collaborations span 23 countries and 18 institutions , with emphasis on global microbiome diversity and synthetic biology applications.